MATEON THERAPEUTICS INC Intellectual Property Contracts & Agreements
8 Contracts & Agreements
- License Agreements (8 contracts)
- License Agreement between Oncotelic Therapeutics, Inc. and Sapu Holdings, LLC dated March 31, 2022 (Filed With SEC on April 6, 2022)
- License Agreement between Oncotelic Therapeutics, Inc. and GMP Biotechnology Limited dated March 31, 2022 (Filed With SEC on April 6, 2022)
- License Agreement between Oncotelic Therapeutics, Inc. and Autotelic, Inc., dated September 30, 2021 (Filed With SEC on October 4, 2021)
- License, Development and Commercialization Agreement between Mateon Therapeutics, Inc. and Windlas Biotech Private Limited dated November 10, 2020 (Filed With SEC on November 16, 2020)
- Agreement for Delivery and Licensed Use of Data Generated from OT-101 U.S. Expanded Access (Data License 1) dated September 5, 2019 between WideTrial and Oncotelic (Filed With SEC on September 10, 2019)
- CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENT (Filed With SEC on March 20, 2014)
- Ex-10.2 Novated and Restated Technology License Agreement (Filed With SEC on October 10, 2008)
- Ex-10.1 Technology License Agreement dated as of October 1, 2008 (Filed With SEC on October 10, 2008)
